ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,460,884 | -83.4% | 70,100 | -80.9% | 0.00% | -81.8% |
Q2 2023 | $8,784,573 | +339.5% | 366,788 | +245.4% | 0.02% | +266.7% |
Q1 2023 | $1,998,684 | +1027.3% | 106,200 | +853.6% | 0.01% | +500.0% |
Q4 2022 | $177,301 | -78.6% | 11,137 | -81.1% | 0.00% | -66.7% |
Q2 2022 | $828,000 | -85.8% | 58,800 | -75.5% | 0.00% | -82.4% |
Q1 2022 | $5,824,000 | +856.3% | 240,471 | +821.3% | 0.02% | +1600.0% |
Q4 2021 | $609,000 | +133.3% | 26,100 | +66.2% | 0.00% | 0.0% |
Q3 2021 | $261,000 | -22.6% | 15,700 | +13.8% | 0.00% | 0.0% |
Q2 2021 | $337,000 | -97.6% | 13,800 | -95.2% | 0.00% | -98.6% |
Q2 2020 | $13,892,000 | +354.3% | 286,618 | +301.0% | 0.07% | +666.7% |
Q4 2019 | $3,058,000 | -59.4% | 71,480 | -65.9% | 0.01% | -64.0% |
Q3 2019 | $7,540,000 | +42.0% | 209,496 | +5.5% | 0.02% | +38.9% |
Q2 2019 | $5,309,000 | +24.9% | 198,623 | +34.8% | 0.02% | +12.5% |
Q4 2016 | $4,250,000 | – | 147,339 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |